|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
LeukoVantage®, Acute Myeloid Leukemia (AML)
Test Code36787 (36787)
Includes
ASXL1, ATM, BCOR, BCORL1, CBL, CDKN2B, CEBPA, CREBP(ATF2), CSF3R, DDX41, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, IKZF1, JAK2, KDM6A, KIT, KRAS, MLL (PTD only), MPL, NF1, NPM1, NRAS, PHF6, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, STK11, TET2, TP53, U2AF1, WT1, ZRSR2 genes
Preferred Specimen
6 mL Lavender Top

Minimum Volume
2 mL
Other Acceptable Specimens
SODIUM HEPARIN, Green Top
Instructions
Requisition form and Pathology/Flow Cytometry Reports are required. In addition, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.
Transport Temperature
Room temperature
Specimen Stability
Whole blood or bone marrow (EDTA)
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable
Whole blood or bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable
Whole blood or bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Frozen • Clotted
Methodology
Next Generation Sequencing • Long Range Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 2 days a week.
Report Available
Reports in 10 to 14 days.
Reference Range
See Laboratory Report
Clinical Significance
This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.

